| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 4.11e-12 | 38 | 87 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.63e-08 | 118 | 87 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.43e-07 | 227 | 87 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.90e-06 | 21 | 87 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 MYO10 MYH7B DAAM1 EPB41L3 TULP1 | 7.32e-06 | 479 | 87 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | calmodulin binding | 7.33e-06 | 230 | 87 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.88e-05 | 2 | 87 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.88e-05 | 2 | 87 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.50e-05 | 15 | 87 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 5.61e-05 | 3 | 87 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.39e-05 | 229 | 87 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.15e-05 | 614 | 87 | 11 | GO:0140657 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 8.44e-05 | 417 | 87 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.97e-04 | 66 | 87 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.97e-04 | 66 | 87 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NEFM MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 MYO10 MYH7B CDK5RAP2 DAAM1 EPB41L3 EP300 TULP1 | 2.70e-04 | 1099 | 87 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | chromatin binding | NCOR1 TCF3 POLR3D WDHD1 POLR3GL MCM3AP NAP1L1 CHD3 CREBBP TRIM37 EP300 | 3.59e-04 | 739 | 87 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 3.97e-04 | 33 | 87 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 5.58e-04 | 37 | 87 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 9.71e-04 | 582 | 87 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone binding | 1.06e-03 | 265 | 87 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 1.23e-03 | 107 | 87 | 4 | GO:0043130 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.36e-03 | 187 | 87 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.43e-03 | 51 | 87 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.60e-03 | 753 | 87 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.78e-03 | 55 | 87 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | adenyl-nucleotide exchange factor activity | 1.90e-03 | 15 | 87 | 2 | GO:0000774 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.10e-03 | 303 | 87 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.29e-03 | 60 | 87 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 2.38e-03 | 128 | 87 | 4 | GO:0032182 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.87e-03 | 65 | 87 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | p53 binding | 4.63e-03 | 77 | 87 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.80e-03 | 78 | 87 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | zinc ion binding | ZCCHC9 UBR5 KDM4C TRIM34 CHD3 MORC3 MDM2 CREBBP TRIM37 EP300 | 5.32e-03 | 891 | 87 | 10 | GO:0008270 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.71e-07 | 15 | 86 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 8.24e-07 | 18 | 86 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | 3.07e-06 | 368 | 86 | 10 | GO:0031647 | |
| GeneOntologyBiologicalProcess | chromatin organization | SETD1A NCOR1 TCF3 BRD8 WDHD1 UBR5 KDM4C MCM3AP NAP1L1 CHD3 DEK DDB1 CREBBP TRIM37 EP300 | 4.01e-06 | 896 | 86 | 15 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SETD1A TCF3 WDHD1 UBR5 KDM4C MCM3AP NAP1L1 CHD3 DEK DDB1 CREBBP TRIM37 EP300 | 1.16e-05 | 741 | 86 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETD1A NCOR1 TCF3 BRD8 WDHD1 UBR5 KDM4C MCM3AP NAP1L1 CHD3 DEK DDB1 CREBBP TRIM37 EP300 | 1.47e-05 | 999 | 86 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.03e-04 | 4 | 86 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | FSIP2 RANBP2 BNIP3L UBR5 UBAP1 DDRGK1 AKAP11 MORC3 MDM2 CREBBP TRIM37 EP300 GOLGB1 TULP1 | 1.58e-04 | 1091 | 86 | 14 | GO:0033365 |
| GeneOntologyBiologicalProcess | DNA damage response | SETD1A BRD8 SNW1 WDHD1 UBR5 CCAR2 MDM2 DEK DDB1 CREBBP NEURL4 EP300 WDR48 | 1.63e-04 | 959 | 86 | 13 | GO:0006974 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.91e-04 | 127 | 86 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | NEFM FSIP2 NCOR1 SLK CDK5RAP2 CHD3 CFAP57 DDB1 TRIM37 AK7 CFAP65 | 1.96e-04 | 720 | 86 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.01e-04 | 202 | 86 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.63e-04 | 136 | 86 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | muscle contraction | 2.65e-04 | 400 | 86 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.89e-04 | 31 | 86 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 3.53e-04 | 145 | 86 | 5 | GO:0001578 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 4.16e-04 | 35 | 86 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 4.16e-04 | 35 | 86 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.52e-04 | 153 | 86 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle system process | 4.56e-04 | 547 | 86 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | negative regulation of centriole replication | 4.73e-04 | 8 | 86 | 2 | GO:0046600 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 4.79e-04 | 155 | 86 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.82e-04 | 87 | 86 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 5.50e-04 | 244 | 86 | 6 | GO:0009755 | |
| GeneOntologyCellularComponent | myosin complex | 3.55e-12 | 59 | 90 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 9.76e-12 | 25 | 90 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.38e-11 | 28 | 90 | 7 | GO:0016460 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.16e-11 | 16 | 90 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.61e-05 | 290 | 90 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SETD1A NCOR1 RANBP2 TCF3 POLR3D BRD8 ELL2 SNW1 POLR3GL MCM3AP ACIN1 CHD3 MGA DEK ANAPC5 CREBBP TRIM37 | 7.09e-05 | 1377 | 90 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | myofibril | 1.78e-04 | 273 | 90 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.85e-04 | 576 | 90 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | box C/D RNP complex | 3.80e-04 | 7 | 90 | 2 | GO:0170049 | |
| GeneOntologyCellularComponent | box C/D methylation guide snoRNP complex | 3.80e-04 | 7 | 90 | 2 | GO:0031428 | |
| GeneOntologyCellularComponent | transferase complex | SETD1A RANBP2 POLR3D BRD8 SNW1 POLR3GL MGA ANAPC5 DDB1 CREBBP TRIM37 EP300 | 8.52e-04 | 963 | 90 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | chromatin | SETD1A NCOR1 TCF3 BRD8 SNW1 UBR5 KDM4C NAP1L1 CCAR2 CHD3 MORC3 MGA DEK CREBBP EP300 | 1.56e-03 | 1480 | 90 | 15 | GO:0000785 |
| HumanPheno | Simple ear | 1.25e-05 | 24 | 32 | 4 | HP:0020206 | |
| HumanPheno | Perimembranous ventricular septal defect | 1.74e-05 | 26 | 32 | 4 | HP:0011682 | |
| HumanPheno | Plantar crease between first and second toes | 3.82e-05 | 2 | 32 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.82e-05 | 2 | 32 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.82e-05 | 2 | 32 | 2 | HP:0001042 | |
| HumanPheno | Facial grimacing | 6.17e-05 | 13 | 32 | 3 | HP:0000273 | |
| HumanPheno | Laryngeal cartilage malformation | 1.14e-04 | 3 | 32 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.14e-04 | 3 | 32 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.14e-04 | 3 | 32 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.14e-04 | 3 | 32 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.14e-04 | 3 | 32 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.14e-04 | 3 | 32 | 2 | HP:0005895 | |
| HumanPheno | Toe deformity | 1.24e-04 | 129 | 32 | 6 | HP:0034398 | |
| HumanPheno | Trichiasis | 2.28e-04 | 4 | 32 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.28e-04 | 4 | 32 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.28e-04 | 4 | 32 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.28e-04 | 4 | 32 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.28e-04 | 4 | 32 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.28e-04 | 4 | 32 | 2 | HP:0031207 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.78e-04 | 5 | 32 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.78e-04 | 5 | 32 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.78e-04 | 5 | 32 | 2 | HP:0030421 | |
| HumanPheno | Everted upper lip vermilion | 4.17e-04 | 24 | 32 | 3 | HP:0010803 | |
| HumanPheno | Prominent nose | 5.42e-04 | 110 | 32 | 5 | HP:0000448 | |
| HumanPheno | Large foramen magnum | 5.65e-04 | 6 | 32 | 2 | HP:0002700 | |
| Domain | Myosin_tail_1 | 5.02e-15 | 18 | 84 | 8 | PF01576 | |
| Domain | Myosin_tail | 5.02e-15 | 18 | 84 | 8 | IPR002928 | |
| Domain | Myosin_N | 1.80e-13 | 15 | 84 | 7 | PF02736 | |
| Domain | Myosin_N | 1.80e-13 | 15 | 84 | 7 | IPR004009 | |
| Domain | Myosin-like_IQ_dom | 1.39e-12 | 19 | 84 | 7 | IPR027401 | |
| Domain | - | 1.39e-12 | 19 | 84 | 7 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 5.22e-12 | 38 | 84 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.22e-12 | 38 | 84 | 8 | PS51456 | |
| Domain | Myosin_head | 5.22e-12 | 38 | 84 | 8 | PF00063 | |
| Domain | MYSc | 5.22e-12 | 38 | 84 | 8 | SM00242 | |
| Domain | IQ | 2.93e-09 | 81 | 84 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 6.85e-09 | 90 | 84 | 8 | IPR000048 | |
| Domain | IQ | 8.90e-09 | 93 | 84 | 8 | PS50096 | |
| Domain | IQ | 3.04e-08 | 71 | 84 | 7 | PF00612 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.00e-05 | 2 | 84 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.00e-05 | 2 | 84 | 2 | PF08214 | |
| Domain | KIX | 2.00e-05 | 2 | 84 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 2.00e-05 | 2 | 84 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.00e-05 | 2 | 84 | 2 | IPR031162 | |
| Domain | DUF902 | 2.00e-05 | 2 | 84 | 2 | PF06001 | |
| Domain | - | 2.00e-05 | 2 | 84 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.00e-05 | 2 | 84 | 2 | IPR010303 | |
| Domain | - | 2.00e-05 | 2 | 84 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 2.00e-05 | 2 | 84 | 2 | PF09030 | |
| Domain | - | 2.00e-05 | 2 | 84 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.00e-05 | 2 | 84 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.00e-05 | 2 | 84 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.00e-05 | 2 | 84 | 2 | IPR013178 | |
| Domain | KAT11 | 2.00e-05 | 2 | 84 | 2 | SM01250 | |
| Domain | Znf_TAZ | 2.00e-05 | 2 | 84 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.00e-05 | 2 | 84 | 2 | IPR003101 | |
| Domain | KIX | 2.00e-05 | 2 | 84 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 2.00e-05 | 2 | 84 | 2 | PS51727 | |
| Domain | Nuc_rcpt_coact | 2.96e-04 | 6 | 84 | 2 | IPR009110 | |
| Domain | BROMODOMAIN_1 | 6.11e-04 | 37 | 84 | 3 | PS00633 | |
| Domain | Bromodomain | 6.61e-04 | 38 | 84 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 8.27e-04 | 41 | 84 | 3 | PS50014 | |
| Domain | BROMO | 8.88e-04 | 42 | 84 | 3 | SM00297 | |
| Domain | Bromodomain | 8.88e-04 | 42 | 84 | 3 | IPR001487 | |
| Domain | - | 8.88e-04 | 42 | 84 | 3 | 1.20.920.10 | |
| Domain | ZZ | 2.92e-03 | 18 | 84 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.92e-03 | 18 | 84 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.92e-03 | 18 | 84 | 2 | PS01357 | |
| Domain | Znf_ZZ | 3.25e-03 | 19 | 84 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.25e-03 | 19 | 84 | 2 | SM00291 | |
| Domain | - | 3.89e-03 | 333 | 84 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.01e-03 | 335 | 84 | 6 | IPR015943 | |
| Domain | zf-RanBP | 4.36e-03 | 22 | 84 | 2 | PF00641 | |
| Domain | SAP | 4.36e-03 | 22 | 84 | 2 | PF02037 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 6.24e-08 | 70 | 72 | 7 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.46e-07 | 132 | 72 | 8 | M11355 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.27e-06 | 22 | 72 | 4 | MM1370 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.12e-05 | 66 | 72 | 5 | M101 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.47e-05 | 14 | 72 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 6.82e-05 | 16 | 72 | 3 | M27121 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.03e-04 | 48 | 72 | 4 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.03e-04 | 48 | 72 | 4 | M611 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.37e-04 | 20 | 72 | 3 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.15e-04 | 58 | 72 | 4 | M29616 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.39e-04 | 24 | 72 | 3 | M13404 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.55e-04 | 5 | 72 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.55e-04 | 5 | 72 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.55e-04 | 5 | 72 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.55e-04 | 5 | 72 | 2 | M27228 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.71e-04 | 25 | 72 | 3 | M27880 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 3.15e-04 | 64 | 72 | 4 | M27046 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.35e-04 | 65 | 72 | 4 | M39682 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.81e-04 | 6 | 72 | 2 | M22062 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.82e-04 | 28 | 72 | 3 | M6177 | |
| Pathway | REACTOME_SUMOYLATION | 4.02e-04 | 189 | 72 | 6 | M27214 | |
| Pathway | KEGG_CELL_CYCLE | 4.40e-04 | 125 | 72 | 5 | M7963 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.66e-04 | 272 | 72 | 7 | M29619 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.31e-04 | 7 | 72 | 2 | MM1573 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 5.31e-04 | 7 | 72 | 2 | M27087 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 5.31e-04 | 7 | 72 | 2 | MM14765 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.50e-04 | 74 | 72 | 4 | M616 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 6.26e-04 | 135 | 72 | 5 | M15247 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.06e-04 | 8 | 72 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 7.06e-04 | 8 | 72 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 7.06e-04 | 8 | 72 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 7.06e-04 | 8 | 72 | 2 | M46443 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.10e-04 | 82 | 72 | 4 | MM15922 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 8.10e-04 | 82 | 72 | 4 | M2 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 9.05e-04 | 9 | 72 | 2 | M47451 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.48e-04 | 38 | 72 | 3 | M27757 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.02e-03 | 39 | 72 | 3 | M29793 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.13e-03 | 10 | 72 | 2 | M27945 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.20e-03 | 91 | 72 | 4 | M39700 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.27e-03 | 42 | 72 | 3 | M17541 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.27e-03 | 42 | 72 | 3 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 1.27e-03 | 42 | 72 | 3 | MM15822 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.37e-03 | 11 | 72 | 2 | M22027 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.37e-03 | 11 | 72 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.37e-03 | 11 | 72 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.37e-03 | 11 | 72 | 2 | M26924 | |
| Pathway | PID_RANBP2_PATHWAY | 1.37e-03 | 11 | 72 | 2 | M140 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.46e-03 | 96 | 72 | 4 | M27784 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.64e-03 | 12 | 72 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.64e-03 | 12 | 72 | 2 | M27765 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.76e-03 | 101 | 72 | 4 | M27253 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.76e-03 | 47 | 72 | 3 | M7946 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SETD1A RANBP2 TCF3 POLR3D ELL2 BNIP3L POLR3GL RPRD2 CHD3 MDM2 MGA DEK EP300 | 1.82e-03 | 1022 | 72 | 13 | MM15436 |
| Pathway | REACTOME_HEME_SIGNALING | 1.99e-03 | 49 | 72 | 3 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.99e-03 | 49 | 72 | 3 | M618 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.23e-03 | 51 | 72 | 3 | M665 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.36e-03 | 52 | 72 | 3 | M2404 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.40e-03 | 110 | 72 | 4 | M48259 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 2.45e-03 | 464 | 72 | 8 | M27547 | |
| Pathway | PID_AR_TF_PATHWAY | 2.49e-03 | 53 | 72 | 3 | M151 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.59e-03 | 15 | 72 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.59e-03 | 15 | 72 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.59e-03 | 15 | 72 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 2.59e-03 | 15 | 72 | 2 | M953 | |
| Pathway | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | 2.59e-03 | 15 | 72 | 2 | MM14782 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.95e-03 | 16 | 72 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.95e-03 | 16 | 72 | 2 | MM1420 | |
| Pathway | KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS | 2.95e-03 | 16 | 72 | 2 | M7528 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.95e-03 | 16 | 72 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.95e-03 | 16 | 72 | 2 | M27940 | |
| Pathway | WP_CELL_CYCLE | 3.29e-03 | 120 | 72 | 4 | M39650 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 3.33e-03 | 17 | 72 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.33e-03 | 17 | 72 | 2 | M48025 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 3.33e-03 | 17 | 72 | 2 | MM14790 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 3.38e-03 | 59 | 72 | 3 | M261 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.72e-03 | 61 | 72 | 3 | M39540 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 3.72e-03 | 61 | 72 | 3 | M152 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.73e-03 | 18 | 72 | 2 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 3.73e-03 | 18 | 72 | 2 | MM15342 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.73e-03 | 18 | 72 | 2 | M26942 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION | 3.73e-03 | 18 | 72 | 2 | M1055 | |
| Pathway | WP_TAR_SYNDROME | 4.07e-03 | 63 | 72 | 3 | M48082 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.16e-03 | 19 | 72 | 2 | M18933 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 4.16e-03 | 19 | 72 | 2 | M27639 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 4.16e-03 | 19 | 72 | 2 | M46442 | |
| Pathway | PID_RB_1PATHWAY | 4.45e-03 | 65 | 72 | 3 | M279 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.71e-16 | 6 | 91 | 6 | 10077619 | |
| Pubmed | 1.90e-15 | 7 | 91 | 6 | 35210422 | ||
| Pubmed | 1.10e-13 | 5 | 91 | 5 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.10e-13 | 5 | 91 | 5 | 3829126 | |
| Pubmed | 6.57e-13 | 6 | 91 | 5 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 6.57e-13 | 6 | 91 | 5 | 10588881 | |
| Pubmed | 2.29e-12 | 7 | 91 | 5 | 16819597 | ||
| Pubmed | NEFM CACNA1E MYH1 NCOR1 MYH2 MYH3 MYH4 RANBP2 MYH8 MYH13 MYH7B CTAGE8 SANBR DDRGK1 ACIN1 CCAR2 CHD3 CTAGE4 EPB41L3 GOLGB1 DNTTIP2 PPL | 1.50e-11 | 1442 | 91 | 22 | 35575683 | |
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 10388558 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 20357587 | ||
| Pubmed | 4.38e-11 | 4 | 91 | 4 | 1985022 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.39e-10 | 13 | 91 | 5 | 8404542 | |
| Pubmed | 2.16e-10 | 14 | 91 | 5 | 27184118 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.19e-10 | 5 | 91 | 4 | 12919077 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.53e-09 | 7 | 91 | 4 | 29758057 | |
| Pubmed | NEFM RANBP2 NOP58 SNW1 UBR5 PDHA1 RRP9 MCM3AP NAP1L1 ACIN1 CCAR2 EPB41L3 DDB1 DNTTIP2 | 1.67e-09 | 653 | 91 | 14 | 22586326 | |
| Pubmed | NEFM SETD1A NCOR1 NOP58 SLK BRD8 SNW1 NAP1L1 ACIN1 RPRD2 MGA CREBBP EP300 | 2.05e-09 | 549 | 91 | 13 | 38280479 | |
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 2.34e-09 | 46 | 91 | 6 | 28827394 | |
| Pubmed | 2.79e-09 | 22 | 91 | 5 | 24301466 | ||
| Pubmed | 3.04e-09 | 8 | 91 | 4 | 3864153 | ||
| Pubmed | 3.04e-09 | 8 | 91 | 4 | 36200826 | ||
| Pubmed | SETD1A RANBP2 NOP58 SNW1 WDHD1 NAP1L1 ACIN1 CCAR2 CHD3 MORC3 DEK DDB1 | 3.79e-09 | 469 | 91 | 12 | 27634302 | |
| Pubmed | NCOR1 RANBP2 NOP58 POLR3D BRD8 SNW1 WDHD1 UBR5 NAP1L1 ACIN1 CCAR2 CHD3 DEK DDB1 CREBBP EP300 | 8.16e-09 | 1014 | 91 | 16 | 32416067 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 9.10e-09 | 10 | 91 | 4 | 8950513 | |
| Pubmed | 9.85e-09 | 58 | 91 | 6 | 21884692 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TCF3 NOP58 POLR3D WDHD1 UBR5 MYO10 SBF2 MCM3AP NAP1L1 UBAP1 CCAR2 RPRD2 DEK ANAPC5 TRIM37 ACAP3 | 1.13e-08 | 1038 | 91 | 16 | 26673895 |
| Pubmed | 1.43e-08 | 11 | 91 | 4 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.43e-08 | 11 | 91 | 4 | 16024798 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.73e-08 | 3 | 91 | 3 | 26059207 | |
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 32098872 | ||
| Pubmed | E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus. | 1.73e-08 | 3 | 91 | 3 | 22544934 | |
| Pubmed | 1.73e-08 | 3 | 91 | 3 | 22387215 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.46e-08 | 33 | 91 | 5 | 32094117 | |
| Pubmed | VGF NEFM CACNA1E NCOR1 RANBP2 SLK SNW1 UBR5 CDK5RAP2 CCAR2 EPB41L3 MGA DDB1 NEURL4 GOLGB1 | 2.99e-08 | 963 | 91 | 15 | 28671696 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.08e-08 | 184 | 91 | 8 | 32908313 | |
| Pubmed | 3.08e-08 | 13 | 91 | 4 | 8948582 | ||
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 4.30e-08 | 14 | 91 | 4 | 15333839 | |
| Pubmed | NCOR1 UBR5 MCM3AP APLP2 CHD3 DAAM1 MGA DDB1 CREBBP GOLGB1 PPL SIL1 | 4.83e-08 | 591 | 91 | 12 | 15231748 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 5.86e-08 | 15 | 91 | 4 | 24852826 | |
| Pubmed | 5.89e-08 | 39 | 91 | 5 | 38690566 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 NOP58 SNW1 UBR5 RRP9 NAP1L1 ACIN1 CCAR2 CHD3 MGA DEK DDB1 NEURL4 GOLGB1 DNTTIP2 | 6.65e-08 | 1024 | 91 | 15 | 24711643 |
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 6.92e-08 | 4 | 91 | 3 | 17073437 | |
| Pubmed | 6.92e-08 | 4 | 91 | 3 | 11023856 | ||
| Pubmed | 6.92e-08 | 4 | 91 | 3 | 22207202 | ||
| Pubmed | p300/CBP-associated factor drives DEK into interchromatin granule clusters. | 6.92e-08 | 4 | 91 | 3 | 15987677 | |
| Pubmed | 6.92e-08 | 4 | 91 | 3 | 11940655 | ||
| Pubmed | p300/MDM2 complexes participate in MDM2-mediated p53 degradation. | 6.92e-08 | 4 | 91 | 3 | 9809062 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 6.92e-08 | 4 | 91 | 3 | 11029314 | |
| Pubmed | Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. | 6.92e-08 | 4 | 91 | 3 | 12435739 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 6.92e-08 | 4 | 91 | 3 | 18417546 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 7.79e-08 | 16 | 91 | 4 | 19922871 | |
| Pubmed | 1.02e-07 | 17 | 91 | 4 | 16124007 | ||
| Pubmed | RANBP2 NOP58 SNW1 PDHA1 RRP9 NAP1L1 ACIN1 CHD3 CFAP57 EPB41L3 DEK DNTTIP2 | 1.16e-07 | 641 | 91 | 12 | 36057605 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 RANBP2 MYH8 MYH13 UBR5 MYH7B NAP1L1 CCAR2 DAAM1 | 1.28e-07 | 647 | 91 | 12 | 26618866 |
| Pubmed | Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner. | 1.65e-07 | 19 | 91 | 4 | 32545337 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.73e-07 | 5 | 91 | 3 | 30737693 | |
| Pubmed | Induction of SOX4 by DNA damage is critical for p53 stabilization and function. | 1.73e-07 | 5 | 91 | 3 | 19234109 | |
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 15225550 | ||
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 6879174 | ||
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 15013777 | ||
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 14985122 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOR1 RANBP2 TCF3 NOP58 BRD8 SNW1 RRP9 ACIN1 RPRD2 CHD3 MGA DEK ANAPC5 DDB1 EP300 DNTTIP2 | 2.31e-07 | 1294 | 91 | 16 | 30804502 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.33e-07 | 332 | 91 | 9 | 32786267 | |
| Pubmed | 3.45e-07 | 6 | 91 | 3 | 24167073 | ||
| Pubmed | CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. | 3.45e-07 | 6 | 91 | 3 | 19805293 | |
| Pubmed | 3.45e-07 | 6 | 91 | 3 | 28549433 | ||
| Pubmed | 3.45e-07 | 6 | 91 | 3 | 18485870 | ||
| Pubmed | Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF. | 3.45e-07 | 6 | 91 | 3 | 17226766 | |
| Pubmed | 3.45e-07 | 6 | 91 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.45e-07 | 6 | 91 | 3 | 17559643 | |
| Pubmed | 6.02e-07 | 7 | 91 | 3 | 27462461 | ||
| Pubmed | The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. | 6.02e-07 | 7 | 91 | 3 | 15154850 | |
| Pubmed | Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. | 6.02e-07 | 7 | 91 | 3 | 12101239 | |
| Pubmed | RANBP2 MCM3AP KIAA1328 APLP2 CGNL1 EPB41L3 MGA CREBBP EP300 GOLGB1 | 6.06e-07 | 486 | 91 | 10 | 20936779 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZCCHC9 NOP58 SNW1 PDHA1 RRP9 ACIN1 CCAR2 CHD3 DEK DDB1 NEURL4 DNTTIP2 | 6.99e-07 | 759 | 91 | 12 | 35915203 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH3 MYH8 SLK MYH13 CDK5RAP2 AKAP11 DEK ANAPC5 CREBBP EP300 DNTTIP2 | 7.22e-07 | 910 | 91 | 13 | 36736316 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.25e-07 | 283 | 91 | 8 | 30585729 | |
| Pubmed | 9.61e-07 | 8 | 91 | 3 | 26993635 | ||
| Pubmed | The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. | 9.61e-07 | 8 | 91 | 3 | 16319895 | |
| Pubmed | 9.61e-07 | 8 | 91 | 3 | 33667029 | ||
| Pubmed | 9.61e-07 | 8 | 91 | 3 | 20935208 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 9.61e-07 | 8 | 91 | 3 | 14667415 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 SLK SNW1 NAP1L1 DDRGK1 ACIN1 RPRD2 CHD3 CGNL1 EPB41L3 DDB1 GOLGB1 DNTTIP2 | 9.65e-07 | 934 | 91 | 13 | 33916271 |
| Pubmed | 1.31e-06 | 31 | 91 | 4 | 21985497 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.35e-06 | 410 | 91 | 9 | 26949251 | |
| Pubmed | 1.44e-06 | 9 | 91 | 3 | 31960486 | ||
| Pubmed | NOP58 SNW1 UBR5 PDHA1 RRP9 DDRGK1 CDK5RAP2 SLC6A15 AKAP11 DAAM1 EPB41L3 DEK DDB1 NEURL4 GOLGB1 DNTTIP2 | 1.45e-06 | 1487 | 91 | 16 | 33957083 | |
| Pubmed | 1.49e-06 | 32 | 91 | 4 | 33732701 | ||
| Pubmed | 1.92e-06 | 34 | 91 | 4 | 30894540 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 2.05e-06 | 10 | 91 | 3 | 2211821 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 2.05e-06 | 10 | 91 | 3 | 30595551 | |
| Pubmed | 2.05e-06 | 10 | 91 | 3 | 19506036 | ||
| Pubmed | Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle. | 2.05e-06 | 10 | 91 | 3 | 29679560 | |
| Pubmed | 2.05e-06 | 10 | 91 | 3 | 20347598 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A RANBP2 NOP58 SNW1 UBR5 PDHA1 MCM3AP NAP1L1 ACIN1 CCAR2 EPB41L3 MGA DDB1 CREBBP DNTTIP2 | 2.24e-06 | 1353 | 91 | 15 | 29467282 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NEFM NCOR1 RANBP2 BRD8 WDHD1 UBR5 CCAR2 MDM2 MGA DEK CREBBP EP300 | 2.46e-06 | 857 | 91 | 12 | 25609649 |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 2.82e-06 | 11 | 91 | 3 | 38303699 | |
| Pubmed | Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2. | 2.82e-06 | 11 | 91 | 3 | 37379210 | |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.82e-06 | 11 | 91 | 3 | 15681609 | |
| Pubmed | 2.82e-06 | 11 | 91 | 3 | 18310078 | ||
| Interaction | TLE3 interactions | MYH1 NCOR1 MYH2 MYH3 MYH4 TCF3 MYH8 BRD8 UBR5 MCM3AP DDB1 CREBBP EP300 | 1.21e-08 | 376 | 90 | 13 | int:TLE3 |
| Interaction | HDAC1 interactions | NEFM MYH1 NCOR1 MYH2 MYH4 RANBP2 MYH8 UBR5 KDM4C DDRGK1 CDK5RAP2 CCAR2 CHD3 EPB41L3 MDM2 MGA DDB1 CREBBP EP300 GOLGB1 | 6.91e-08 | 1108 | 90 | 20 | int:HDAC1 |
| Interaction | PPARG interactions | NCOR1 NOP58 BRD8 UBR5 KDM4C RRP9 MDM2 CREBBP TRIM37 EP300 DNTTIP2 | 1.22e-07 | 307 | 90 | 11 | int:PPARG |
| Interaction | RSPH6A interactions | 3.99e-07 | 34 | 90 | 5 | int:RSPH6A | |
| Interaction | CREBBP interactions | SETD1A NCOR1 TCF3 BNIP3L NAP1L1 CCAR2 CHD3 MDM2 MGA DEK ANAPC5 DDB1 CREBBP EP300 | 4.08e-07 | 599 | 90 | 14 | int:CREBBP |
| Interaction | TSPAN33 interactions | 4.48e-07 | 65 | 90 | 6 | int:TSPAN33 | |
| Interaction | DAXX interactions | SETD1A RANBP2 ZCCHC9 TCF3 SNW1 TRIM34 MORC3 MDM2 DEK CREBBP EP300 | 4.93e-07 | 353 | 90 | 11 | int:DAXX |
| Interaction | MECOM interactions | MYH1 MYH2 MYH4 NOP58 MYH8 NAP1L1 CHD3 EPB41L3 DDB1 CREBBP TRIM37 | 5.67e-07 | 358 | 90 | 11 | int:MECOM |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH3 MYH4 NOP58 MYH8 MYH13 CDK5RAP2 MDM2 MGA DDB1 CREBBP | 5.94e-07 | 440 | 90 | 12 | int:LATS1 |
| Interaction | RBBP5 interactions | 6.15e-07 | 287 | 90 | 10 | int:RBBP5 | |
| Interaction | NUP43 interactions | FSIP2 SETD1A NCOR1 RANBP2 NOP58 BRD8 UBR5 MCM3AP ACIN1 CCAR2 CHD3 MGA DDB1 DNTTIP2 | 6.78e-07 | 625 | 90 | 14 | int:NUP43 |
| Interaction | SLC39A3 interactions | 6.98e-07 | 70 | 90 | 6 | int:SLC39A3 | |
| Interaction | SIRT6 interactions | SETD1A RANBP2 WDHD1 UBR5 RRP9 CCAR2 RPRD2 CHD3 MDM2 ANAPC5 DDB1 CREBBP EP300 DNTTIP2 | 7.18e-07 | 628 | 90 | 14 | int:SIRT6 |
| Interaction | SUZ12 interactions | VGF SETD1A RANBP2 NOP58 SNW1 WDHD1 ACIN1 CDK5RAP2 CCAR2 CHD3 MORC3 MDM2 DDB1 TRIM37 | 9.67e-07 | 644 | 90 | 14 | int:SUZ12 |
| Interaction | SIRT7 interactions | NEFM RANBP2 NOP58 SNW1 UBR5 PDHA1 RRP9 MCM3AP NAP1L1 ACIN1 CCAR2 EPB41L3 MDM2 DDB1 DNTTIP2 | 9.77e-07 | 744 | 90 | 15 | int:SIRT7 |
| Interaction | ACTN2 interactions | 9.78e-07 | 171 | 90 | 8 | int:ACTN2 | |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 MYO10 MYH7B SH3GL3 DDRGK1 ACIN1 SLC6A15 TRIM37 | 1.06e-06 | 554 | 90 | 13 | int:BCAP31 |
| Interaction | DDX23 interactions | NEFM NOP58 SLK SNW1 WDHD1 UBR5 DDRGK1 ACIN1 CHD3 DDB1 EP300 DNTTIP2 | 1.48e-06 | 480 | 90 | 12 | int:DDX23 |
| Interaction | SUB1 interactions | 1.61e-06 | 247 | 90 | 9 | int:SUB1 | |
| Interaction | ASAH2 interactions | 1.71e-06 | 6 | 90 | 3 | int:ASAH2 | |
| Interaction | PCNA interactions | RANBP2 TCF3 WDHD1 UBR5 DDRGK1 MDM2 DDB1 CREBBP TRIM37 EP300 DNTTIP2 WDR48 | 2.12e-06 | 497 | 90 | 12 | int:PCNA |
| Interaction | MYB interactions | 2.20e-06 | 133 | 90 | 7 | int:MYB | |
| Interaction | NR1I2 interactions | 2.34e-06 | 48 | 90 | 5 | int:NR1I2 | |
| Interaction | H2BC21 interactions | CACNA1E NAP1L1 AKAP11 RPRD2 ARHGAP30 EPB41L3 MDM2 DEK ANAPC5 DDB1 CREBBP EP300 DNTTIP2 WDR48 | 2.41e-06 | 696 | 90 | 14 | int:H2BC21 |
| Interaction | U2SURP interactions | 3.57e-06 | 349 | 90 | 10 | int:U2SURP | |
| Interaction | BAG2 interactions | SETD1A NCOR1 SLK BRD8 SNW1 WDHD1 MYO10 CCAR2 RPRD2 ANAPC5 CREBBP TRIM37 EP300 | 3.78e-06 | 622 | 90 | 13 | int:BAG2 |
| Interaction | NCOA1 interactions | 4.10e-06 | 146 | 90 | 7 | int:NCOA1 | |
| Interaction | HIF1A interactions | MYH1 MYH2 MYH3 MYH4 KDM4C CCAR2 MDM2 DDB1 CREBBP TRIM37 EP300 | 4.28e-06 | 441 | 90 | 11 | int:HIF1A |
| Interaction | PARP1 interactions | SETD1A TCF3 NOP58 WDHD1 SH3GL3 NAP1L1 DDRGK1 CDK5RAP2 CCAR2 CHD3 CGNL1 MORC3 MDM2 MGA CERT1 CREBBP TRIM37 EP300 DNTTIP2 | 4.47e-06 | 1316 | 90 | 19 | int:PARP1 |
| Interaction | CSNK2A1 interactions | SETD1A NCOR1 NOP58 RRP9 NAP1L1 ACIN1 RPRD2 CHD3 EPB41L3 MDM2 MGA DEK DDB1 CREBBP EP300 WDR48 | 4.58e-06 | 956 | 90 | 16 | int:CSNK2A1 |
| Interaction | IYD interactions | 7.10e-06 | 9 | 90 | 3 | int:IYD | |
| Interaction | RBBP4 interactions | SETD1A NCOR1 TCF3 WDHD1 MYO10 NAP1L1 DDRGK1 CDK5RAP2 CHD3 DDB1 CREBBP EP300 | 9.05e-06 | 573 | 90 | 12 | int:RBBP4 |
| Interaction | H3C1 interactions | SETD1A NCOR1 SNW1 PDHA1 KDM4C NAP1L1 CHD3 MORC3 MGA DEK ANAPC5 DDB1 CREBBP EP300 DNTTIP2 | 1.01e-05 | 901 | 90 | 15 | int:H3C1 |
| Interaction | SSRP1 interactions | NCOR1 RANBP2 SNW1 WDHD1 UBR5 NAP1L1 DDRGK1 ACIN1 RPRD2 CHD3 MORC3 DDB1 EP300 | 1.07e-05 | 685 | 90 | 13 | int:SSRP1 |
| Interaction | RANGAP1 interactions | 1.13e-05 | 314 | 90 | 9 | int:RANGAP1 | |
| Interaction | HSPB8 interactions | 1.20e-05 | 172 | 90 | 7 | int:HSPB8 | |
| Interaction | CDK3 interactions | 1.21e-05 | 114 | 90 | 6 | int:CDK3 | |
| Interaction | LUC7L interactions | 1.28e-05 | 242 | 90 | 8 | int:LUC7L | |
| Interaction | PRKAG2 interactions | 1.33e-05 | 68 | 90 | 5 | int:PRKAG2 | |
| Interaction | H2AC4 interactions | SETD1A NOP58 UBR5 PDHA1 NAP1L1 CHD3 ANAPC5 DDB1 CREBBP TRIM37 EP300 | 1.56e-05 | 506 | 90 | 11 | int:H2AC4 |
| Interaction | YWHAZ interactions | NEFM FSIP2 NCOR1 FAM163A SLK PANK2 DDRGK1 CDK5RAP2 CCAR2 AKAP11 CGNL1 MORC3 EPB41L3 MDM2 DEK TRIM37 EP300 SIL1 | 1.80e-05 | 1319 | 90 | 18 | int:YWHAZ |
| Interaction | RUVBL2 interactions | SETD1A NOP58 SLK BRD8 SNW1 UBR5 PDHA1 CCAR2 MDM2 MGA DDB1 EP300 | 1.86e-05 | 616 | 90 | 12 | int:RUVBL2 |
| Interaction | MYH4 interactions | 1.88e-05 | 73 | 90 | 5 | int:MYH4 | |
| Interaction | KPNA2 interactions | SETD1A RANBP2 NOP58 SNW1 WDHD1 UBR5 DDRGK1 CHD3 MORC3 CREBBP EP300 | 1.97e-05 | 519 | 90 | 11 | int:KPNA2 |
| Interaction | TGS1 interactions | 2.14e-05 | 75 | 90 | 5 | int:TGS1 | |
| Interaction | TRIM37 interactions | NCOR1 MYH2 MYH4 SNW1 MYH13 UBR5 MCM3AP CDK5RAP2 CCAR2 RPRD2 MGA TRIM37 | 2.32e-05 | 630 | 90 | 12 | int:TRIM37 |
| Interaction | TMEM260 interactions | 2.38e-05 | 13 | 90 | 3 | int:TMEM260 | |
| Interaction | TULP3 interactions | 2.43e-05 | 346 | 90 | 9 | int:TULP3 | |
| Interaction | ZSCAN5A interactions | 2.44e-05 | 38 | 90 | 4 | int:ZSCAN5A | |
| Interaction | SRRM1 interactions | 2.54e-05 | 348 | 90 | 9 | int:SRRM1 | |
| Interaction | MYOD1 interactions | 2.62e-05 | 194 | 90 | 7 | int:MYOD1 | |
| Interaction | WDR5 interactions | SETD1A RANBP2 NOP58 SNW1 UBR5 RRP9 DDRGK1 ACIN1 CHD3 MDM2 MGA DEK DDB1 CREBBP EP300 GOLGB1 | 2.65e-05 | 1101 | 90 | 16 | int:WDR5 |
| Interaction | KPNA1 interactions | 2.72e-05 | 351 | 90 | 9 | int:KPNA1 | |
| Interaction | HECTD1 interactions | ZCCHC9 NOP58 SNW1 PDHA1 RRP9 NAP1L1 ACIN1 CCAR2 CHD3 EPB41L3 DEK DDB1 NEURL4 EP300 DNTTIP2 | 2.83e-05 | 984 | 90 | 15 | int:HECTD1 |
| Interaction | AR interactions | NCOR1 BRD8 SNW1 UBR5 KDM4C ACIN1 CCAR2 RPRD2 CHD3 MORC3 MDM2 MGA CREBBP EP300 WDR48 | 3.11e-05 | 992 | 90 | 15 | int:AR |
| Interaction | KAT5 interactions | 3.17e-05 | 358 | 90 | 9 | int:KAT5 | |
| Interaction | HNF4A interactions | 3.20e-05 | 275 | 90 | 8 | int:HNF4A | |
| Interaction | DYRK1A interactions | WDHD1 MYO10 NAP1L1 CDK5RAP2 AKAP11 MDM2 ANAPC5 CREBBP EP300 GOLGB1 PPL | 3.47e-05 | 552 | 90 | 11 | int:DYRK1A |
| Interaction | UBE2S interactions | 3.59e-05 | 138 | 90 | 6 | int:UBE2S | |
| Interaction | BMI1 interactions | RANBP2 NOP58 SNW1 UBR5 ACIN1 CHD3 CGNL1 MGA DEK CREBBP TRIM37 EP300 | 3.60e-05 | 659 | 90 | 12 | int:BMI1 |
| Interaction | H2AC25 interactions | 3.71e-05 | 84 | 90 | 5 | int:H2AC25 | |
| Interaction | SF3B3 interactions | NCOR1 TCF3 SNW1 DDRGK1 CCAR2 CHD3 MDM2 ANAPC5 TRIM37 EP300 GOLGB1 | 3.83e-05 | 558 | 90 | 11 | int:SF3B3 |
| Interaction | EEF1G interactions | SNW1 UBR5 PDHA1 DDRGK1 ACIN1 CDK5RAP2 CGNL1 DDB1 TRIM37 EP300 | 4.12e-05 | 463 | 90 | 10 | int:EEF1G |
| Interaction | CCND1 interactions | 4.23e-05 | 286 | 90 | 8 | int:CCND1 | |
| Interaction | PRMT5 interactions | RANBP2 TCF3 KDM4C DDRGK1 CCAR2 USP35 EPB41L3 PPCS DDB1 EP300 | 4.76e-05 | 471 | 90 | 10 | int:PRMT5 |
| Interaction | C6orf141 interactions | 5.75e-05 | 92 | 90 | 5 | int:C6orf141 | |
| Interaction | XRCC6 interactions | NCOR1 SNW1 DDRGK1 ACIN1 RPRD2 CHD3 USP35 MDM2 MGA CREBBP TRIM37 EP300 DNTTIP2 ACAP3 | 6.04e-05 | 928 | 90 | 14 | int:XRCC6 |
| Interaction | BCOR interactions | 6.20e-05 | 302 | 90 | 8 | int:BCOR | |
| Interaction | MYH6 interactions | 6.37e-05 | 94 | 90 | 5 | int:MYH6 | |
| Interaction | SUMO2 interactions | NCOR1 RANBP2 NOP58 SNW1 WDHD1 NAP1L1 ACIN1 CCAR2 CHD3 MORC3 EP300 | 6.42e-05 | 591 | 90 | 11 | int:SUMO2 |
| Interaction | RB1 interactions | 6.66e-05 | 394 | 90 | 9 | int:RB1 | |
| Interaction | SMU1 interactions | 7.09e-05 | 227 | 90 | 7 | int:SMU1 | |
| Interaction | H3C3 interactions | 7.20e-05 | 495 | 90 | 10 | int:H3C3 | |
| Interaction | FOS interactions | 7.78e-05 | 312 | 90 | 8 | int:FOS | |
| Interaction | NEUROG1 interactions | 7.92e-05 | 19 | 90 | 3 | int:NEUROG1 | |
| Interaction | HDAC3 interactions | 7.96e-05 | 313 | 90 | 8 | int:HDAC3 | |
| Interaction | DHX15 interactions | 8.09e-05 | 502 | 90 | 10 | int:DHX15 | |
| Interaction | RYBP interactions | 8.13e-05 | 232 | 90 | 7 | int:RYBP | |
| Interaction | BUB3 interactions | 8.13e-05 | 232 | 90 | 7 | int:BUB3 | |
| Interaction | WDR3 interactions | 8.19e-05 | 160 | 90 | 6 | int:WDR3 | |
| Interaction | ABTB2 interactions | 8.97e-05 | 101 | 90 | 5 | int:ABTB2 | |
| Interaction | PRC1 interactions | RANBP2 NOP58 SNW1 PDHA1 RRP9 NAP1L1 DDRGK1 ACIN1 CDK5RAP2 DEK DDB1 TRIM37 GOLGB1 DNTTIP2 | 1.00e-04 | 973 | 90 | 14 | int:PRC1 |
| Interaction | DDX41 interactions | 1.00e-04 | 166 | 90 | 6 | int:DDX41 | |
| Interaction | MAP4 interactions | 1.01e-04 | 324 | 90 | 8 | int:MAP4 | |
| Interaction | CBL interactions | 1.01e-04 | 516 | 90 | 10 | int:CBL | |
| Interaction | TUBB interactions | RANBP2 SNW1 UBR5 PDHA1 MCM3AP DDRGK1 CHD3 DAAM1 MDM2 DDB1 CREBBP TRIM37 | 1.02e-04 | 735 | 90 | 12 | int:TUBB |
| Interaction | PPP1CC interactions | NCOR1 SNW1 UBR5 NAP1L1 DDRGK1 ACIN1 AKAP11 RPRD2 CHD3 CREBBP TRIM37 EP300 | 1.06e-04 | 738 | 90 | 12 | int:PPP1CC |
| Interaction | ACE2 interactions | RANBP2 NOP58 SNW1 PDHA1 RRP9 NAP1L1 ACIN1 CHD3 CFAP57 EPB41L3 MDM2 DEK CREBBP GOLGB1 DNTTIP2 | 1.07e-04 | 1106 | 90 | 15 | int:ACE2 |
| Interaction | HOXB4 interactions | 1.08e-04 | 21 | 90 | 3 | int:HOXB4 | |
| Interaction | TP73 interactions | 1.11e-04 | 169 | 90 | 6 | int:TP73 | |
| Interaction | RXRA interactions | 1.11e-04 | 169 | 90 | 6 | int:RXRA | |
| Interaction | TWIST1 interactions | 1.14e-04 | 170 | 90 | 6 | int:TWIST1 | |
| Interaction | CDC16 interactions | 1.17e-04 | 246 | 90 | 7 | int:CDC16 | |
| Interaction | YWHAQ interactions | MYH2 TCF3 FAM163A SLK PANK2 MYH13 WDHD1 DDRGK1 CCAR2 AKAP11 CGNL1 EPB41L3 MDM2 TRIM37 GOLGB1 | 1.20e-04 | 1118 | 90 | 15 | int:YWHAQ |
| Interaction | SMC5 interactions | MYH1 NCOR1 MYH4 RANBP2 NOP58 BRD8 SNW1 ACIN1 RPRD2 CHD3 EPB41L3 MGA DEK DNTTIP2 | 1.34e-04 | 1000 | 90 | 14 | int:SMC5 |
| Interaction | EP300 interactions | SETD1A NCOR1 TCF3 NOP58 SLK SNW1 WDHD1 MCM3AP NAP1L1 CCAR2 CHD3 MDM2 DEK ANAPC5 DDB1 CREBBP EP300 | 1.37e-04 | 1401 | 90 | 17 | int:EP300 |
| Interaction | COPS2 interactions | 1.57e-04 | 258 | 90 | 7 | int:COPS2 | |
| Interaction | SUPT16H interactions | 1.59e-04 | 442 | 90 | 9 | int:SUPT16H | |
| Interaction | SBDS interactions | 1.61e-04 | 181 | 90 | 6 | int:SBDS | |
| Interaction | SND1 interactions | 1.62e-04 | 347 | 90 | 8 | int:SND1 | |
| Cytoband | 17p13.1 | 1.41e-07 | 118 | 91 | 6 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 4.74e-07 | 346 | 91 | 8 | chr17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 1.57e-04 | 135 | 91 | 4 | chr8p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.59e-04 | 404 | 91 | 6 | chr1q21 | |
| Cytoband | 1q21.1 | 2.62e-04 | 62 | 91 | 3 | 1q21.1 | |
| Cytoband | 8p21 | 7.21e-04 | 20 | 91 | 2 | 8p21 | |
| Cytoband | 17p13 | 2.09e-03 | 34 | 91 | 2 | 17p13 | |
| GeneFamily | Myosin heavy chains | 1.33e-14 | 15 | 57 | 7 | 1098 | |
| GeneFamily | CTAGE family | 9.99e-04 | 15 | 57 | 2 | 907 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.29e-03 | 17 | 57 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.45e-03 | 18 | 57 | 2 | 91 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.97e-03 | 21 | 57 | 2 | 89 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.37e-03 | 23 | 57 | 2 | 662 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.04e-03 | 206 | 57 | 4 | 682 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.31e-07 | 20 | 91 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 7.78e-07 | 21 | 91 | 4 | MM1102 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZCCHC9 SLK BNIP3L WDHD1 MYO10 NAP1L1 CDK5RAP2 AKAP11 DAAM1 EPB41L3 DEK GOLGB1 | 2.84e-06 | 656 | 91 | 12 | M18979 |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 7.74e-06 | 206 | 91 | 7 | M39254 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 SLK ELL2 SNW1 WDHD1 UBR5 KDM4C MYO10 AKAP11 DAAM1 DEK CREBBP TRIM37 | 8.02e-06 | 856 | 91 | 13 | M4500 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 2.35e-05 | 48 | 91 | 4 | M16123 | |
| Coexpression | HEDENFALK_BREAST_CANCER_BRACX_DN | 4.42e-05 | 20 | 91 | 3 | M8941 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 4.53e-05 | 481 | 91 | 9 | M3898 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_DN | 6.93e-05 | 199 | 91 | 6 | M4852 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 7.12e-05 | 200 | 91 | 6 | M8203 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.79e-07 | 62 | 91 | 5 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.79e-07 | 62 | 91 | 5 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 1.51e-06 | 173 | 91 | 6 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 174 | 91 | 6 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 187 | 91 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-06 | 198 | 91 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.58e-06 | 113 | 91 | 5 | 6f270b7e59c18243e876311df721e948ce21e850 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.89e-05 | 77 | 91 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 2.52e-05 | 169 | 91 | 5 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 170 | 91 | 5 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.98e-05 | 175 | 91 | 5 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 181 | 91 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 185 | 91 | 5 | ff95a45b7cb782961bb8f008b6b507af2d4cb8b7 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 186 | 91 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.53e-05 | 191 | 91 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.76e-05 | 193 | 91 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.87e-05 | 194 | 91 | 5 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-05 | 103 | 91 | 4 | 1b2edf25d6b845e7c07470b2a034654d63917c01 | |
| Drug | formycin triphosphate | 2.40e-11 | 51 | 90 | 8 | CID000122274 | |
| Drug | purealin | 7.08e-11 | 58 | 90 | 8 | CID006419303 | |
| Drug | fast white | 2.87e-10 | 42 | 90 | 7 | CID000024008 | |
| Drug | AC1NRBPQ | 3.71e-09 | 137 | 90 | 9 | CID005288569 | |
| Drug | S-(-)-Etomoxir | 6.00e-09 | 100 | 90 | 8 | CID000060765 | |
| Drug | blebbistatin | 1.95e-08 | 116 | 90 | 8 | CID003476986 | |
| Drug | B0683 | 2.08e-08 | 117 | 90 | 8 | CID006398969 | |
| Drug | 2bq7 | 3.09e-08 | 123 | 90 | 8 | CID006540267 | |
| Drug | SM-2 | 5.38e-08 | 87 | 90 | 7 | CID000486033 | |
| Drug | clenbuterol | 9.46e-08 | 142 | 90 | 8 | CID000002783 | |
| Drug | oxovanadium | 4.93e-07 | 120 | 90 | 7 | CID000024411 | |
| Drug | NSC339663 | 6.54e-07 | 250 | 90 | 9 | CID000003892 | |
| Drug | AC1LADJ6 | 8.48e-07 | 130 | 90 | 7 | CID000486032 | |
| Drug | creatine | 9.87e-07 | 193 | 90 | 8 | CID000000586 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 1.03e-06 | 194 | 90 | 8 | 1715_DN | |
| Drug | 4-chloroaniline | 1.39e-06 | 202 | 90 | 8 | CID000007812 | |
| Drug | pyrophosphate | MYH1 MYH2 MYH3 MYH4 MYH8 POLR3D MYH13 POLR3GL MYO10 MYH7B PPCS ANAPC5 AK7 | 1.74e-06 | 654 | 90 | 13 | CID000001023 |
| Drug | candesartan cilexetil | 1.77e-06 | 145 | 90 | 7 | CID000002540 | |
| Drug | eye gene | 2.00e-06 | 369 | 90 | 10 | CID000004782 | |
| Drug | AC1N9ZZC | 2.12e-06 | 149 | 90 | 7 | CID004369374 | |
| Drug | AC1L1IZ2 | 3.28e-06 | 304 | 90 | 9 | CID000004795 | |
| Drug | carvedilol | 3.54e-06 | 161 | 90 | 7 | CID000002585 | |
| Drug | trifluoperazine | 5.50e-06 | 324 | 90 | 9 | CID000005566 | |
| Drug | NSC611747 | 1.07e-05 | 352 | 90 | 9 | CID000002534 | |
| Drug | MgCl2 | 1.12e-05 | 354 | 90 | 9 | CID000024584 | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HG-U133A | 1.12e-05 | 192 | 90 | 7 | 1937_DN | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HG-U133A | 1.42e-05 | 199 | 90 | 7 | 1889_DN | |
| Drug | wartmannin | MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 MYO10 MYH7B SBF2 CDK5RAP2 MDM2 EP300 GOLGB1 | 1.76e-05 | 811 | 90 | 13 | CID000005691 |
| Drug | nocodazole | 1.90e-05 | 477 | 90 | 10 | CID000004122 | |
| Drug | NSC107658 | 2.90e-05 | 306 | 90 | 8 | CID000002919 | |
| Drug | D-triiodothyronine | 3.49e-05 | 409 | 90 | 9 | CID000000861 | |
| Drug | TiNi | 4.83e-05 | 100 | 90 | 5 | CID000159408 | |
| Drug | 4-epidoxorubicin | MYH1 MYH2 MYH3 MYH4 GJA8 MYH8 MYH13 MYH7B TRIM34 MDM2 DEK EP300 | 6.26e-05 | 788 | 90 | 12 | CID000001690 |
| Drug | AC1ND2OB | 8.77e-05 | 265 | 90 | 7 | CID004568637 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 9.11e-05 | 184 | 90 | 6 | 1321_DN | |
| Drug | halofenate | 9.22e-05 | 4 | 90 | 2 | CID000033584 | |
| Drug | BAPPs | 9.22e-05 | 4 | 90 | 2 | CID000134312 | |
| Drug | Spermine | 1.14e-04 | 63 | 90 | 4 | ctd:D013096 | |
| Drug | sulindac sulfide; Up 200; 50uM; MCF7; HG-U133A | 1.22e-04 | 194 | 90 | 6 | 308_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 1.25e-04 | 195 | 90 | 6 | 1927_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A | 1.25e-04 | 195 | 90 | 6 | 1431_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A | 1.29e-04 | 196 | 90 | 6 | 1948_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 90 | 6 | 7217_DN | |
| Drug | hexane | 1.53e-04 | 68 | 90 | 4 | CID000008058 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.53e-04 | 5 | 90 | 2 | ctd:C575894 | |
| Drug | NPCB | 1.53e-04 | 5 | 90 | 2 | CID000146853 | |
| Drug | LY294002 | MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 MYH7B SBF2 CDK5RAP2 MDM2 EP300 | 1.76e-04 | 748 | 90 | 11 | CID000003973 |
| Drug | N-ethylmaleimide | 1.90e-04 | 511 | 90 | 9 | CID000004362 | |
| Drug | indole-3-butyric acid | 2.03e-04 | 29 | 90 | 3 | CID000008617 | |
| Drug | tetrac | 2.03e-04 | 29 | 90 | 3 | CID000065552 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.66e-16 | 10 | 86 | 7 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.09e-15 | 12 | 86 | 7 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.09e-15 | 12 | 86 | 7 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.35e-15 | 13 | 86 | 7 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.79e-15 | 15 | 86 | 7 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 9.12e-11 | 80 | 86 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 9.31e-11 | 48 | 86 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.59e-09 | 71 | 86 | 7 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 8.40e-06 | 2 | 86 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 8.40e-06 | 2 | 86 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 8.40e-06 | 2 | 86 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 8.40e-06 | 2 | 86 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 8.40e-06 | 2 | 86 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 8.40e-06 | 2 | 86 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 8.40e-06 | 2 | 86 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 8.40e-06 | 2 | 86 | 2 | C0035934 | |
| Disease | T-Cell Lymphoma | 1.30e-05 | 16 | 86 | 3 | C0079772 | |
| Disease | Prostatic Neoplasms | 7.83e-05 | 616 | 86 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.83e-05 | 616 | 86 | 9 | C0376358 | |
| Disease | Carcinoma, Transitional Cell | 2.35e-04 | 41 | 86 | 3 | C0007138 | |
| Disease | Distal arthrogryposis | 2.98e-04 | 9 | 86 | 2 | cv:C0265213 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 NOP58 SLK ELL2 BNIP3L WDHD1 UBR5 TRIM34 MDM2 GOLGB1 ARMH4 | 3.62e-04 | 1105 | 86 | 11 | EFO_0004528 |
| Disease | Macrocephaly | 4.54e-04 | 11 | 86 | 2 | C0221355 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.44e-04 | 12 | 86 | 2 | C0023485 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 7.61e-04 | 61 | 86 | 3 | C1961102 | |
| Disease | alcohol consumption measurement | CACNA1E SETD1A BNIP3L KDM4C CDK5RAP2 AKAP11 RPRD2 MGA EP300 SIL1 ARMH4 | 9.54e-04 | 1242 | 86 | 11 | EFO_0007878 |
| Disease | cortical thickness change measurement, age at assessment | 2.04e-03 | 23 | 86 | 2 | EFO_0008007, EFO_0021501 | |
| Disease | Adenocarcinoma of large intestine | 2.81e-03 | 96 | 86 | 3 | C1319315 | |
| Disease | Sezary Syndrome | 2.81e-03 | 27 | 86 | 2 | C0036920 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEEEQKEREKEAERE | 1256 | Q9UKV3 | |
| EEATKEEEAIKEEVV | 581 | Q8N163 | |
| ETEERSTELKTEIKE | 1011 | Q09472 | |
| ETIEEKEEDLKREEE | 481 | O00472 | |
| EEEEKLSRVEEKISR | 411 | Q8IX94 | |
| EEEEKLSRVEEKISR | 411 | P0CG41 | |
| EAEIREDEEEVEKKK | 1101 | Q15878 | |
| LEEEEAEVKRKATDA | 151 | Q9H0E9 | |
| ELIRDSGKTEEEKED | 486 | Q86TY3 | |
| LEQEEEERKKEESTA | 1556 | Q92793 | |
| EVETDVVEIEAKLDK | 21 | Q96P50 | |
| AEKIVAEAIEKAERE | 1651 | Q9UKA4 | |
| EEEQKEEEERKAREE | 166 | Q96HY6 | |
| EEDLREKEREIATEK | 296 | Q96SN8 | |
| EKVELVTGEEDEKVL | 2021 | P49792 | |
| EVEEEETGEETKLKA | 21 | P55209 | |
| EKISEECDIEEKTEV | 66 | P0C860 | |
| IDEDDEKSLREKTVT | 311 | Q8IXS6 | |
| KMEKEELDVSVREEE | 186 | Q9UJX4 | |
| TKIIGSVSKEEEEED | 206 | Q06481 | |
| KDELQRDKVVEDDED | 191 | Q9Y5P4 | |
| EEEEKVAEEEETSVK | 471 | Q9Y2X3 | |
| EEEGIREEEEQLKEK | 1121 | Q8IWI9 | |
| DELVAFEVERIKVEE | 431 | Q86WG5 | |
| FEETKKQIEEDEDRE | 856 | Q96MR6 | |
| EEKEEERDEKEEKVS | 1796 | Q6ZU64 | |
| EEETESREKKEDSLR | 396 | O60318 | |
| EEKEEEVTEAIRETK | 366 | Q5BJE1 | |
| EKEEEEREKEKVREE | 5746 | Q5CZC0 | |
| GKVKELSERLEDEEE | 966 | A7E2Y1 | |
| KIKEVTERAEEEEEI | 921 | P13535 | |
| SLVVKKEETVEDEID | 646 | Q14149 | |
| LEAKIKEVTERAEDE | 921 | Q9UKX2 | |
| SEVDRKIAEKDEEID | 1576 | Q9UKX2 | |
| EVLKVEKDAATEREV | 1116 | O60437 | |
| VVETTDTEDEREKKR | 56 | A6NIU2 | |
| EEEKKKREEEERERE | 826 | Q9HD67 | |
| KRPKADEEEEVSDEV | 381 | Q9H3R0 | |
| AKIKEVTERAEDEEE | 921 | P12882 | |
| EIIKEEEEGKDIEEG | 426 | P23471 | |
| IKELARVSEEKEVTE | 106 | Q86T90 | |
| EEEEEEVESLKSIRK | 236 | Q9BZ23 | |
| SEEEIEKGVEIEEKI | 281 | Q9HAB8 | |
| ALEKEEEEERSKTIE | 121 | Q9Y4D1 | |
| EEAEEEIDRLESSKK | 1216 | Q0VF96 | |
| HQEEDEEEEKEERKR | 131 | I3L3R5 | |
| EDKIEEIEREIIKQE | 1296 | Q12873 | |
| EEEEEEEKEKSLIVE | 41 | P35659 | |
| VGEKKEEAERLTTEE | 346 | P48165 | |
| EEEVVEGEKEVEALK | 121 | O60238 | |
| DEEVKEEDTEQKRET | 216 | O94769 | |
| KKSGTEVADEEEERE | 36 | Q96GL9 | |
| VEDDGSKIIVEDRKE | 376 | Q5VT52 | |
| KREATADDLIKVVEE | 1121 | Q16531 | |
| EKKAEEERDEEEDKR | 471 | Q9Y2J2 | |
| RAEEVFEVKVEELDE | 951 | Q96JN8 | |
| EYTDEKEKEIEREED | 741 | Q7Z6I6 | |
| KEKEIEREEDEQREE | 746 | Q7Z6I6 | |
| VAEETVIKEEEEEKL | 316 | Q8TAK5 | |
| AVKVKEEPRDEEEEA | 216 | P05423 | |
| LETLEKKEEEVTSEE | 151 | Q9BT43 | |
| KVVKRELDDDVTESV | 6 | Q9H2J7 | |
| EEAEKLEADIREEKT | 156 | Q9BYJ4 | |
| VREAKEDEEDEEKIQ | 491 | O94972 | |
| EAKAEVTEEVEDGKE | 306 | Q9H2G2 | |
| ADDVVSIIEEVEEKR | 466 | O15240 | |
| EEVRQAVEKFEESKE | 181 | Q99963 | |
| DVDRIKKDEEEEEDQ | 1236 | Q6P3W6 | |
| VDRIKKDEEEEEDQD | 1481 | Q6P3W6 | |
| LDVDRTKKDQEEEED | 376 | P0DPF2 | |
| LDVDRTKKDQEEEED | 1596 | P0DPF2 | |
| LDVDRTKKDQEEEED | 2816 | P0DPF2 | |
| LDVDRTKKDQEEEED | 4036 | P0DPF2 | |
| KDKIDGTAEETEERE | 551 | O75376 | |
| VKEFEREETQDKEES | 411 | Q00987 | |
| TERKETKAEEELDAE | 51 | Q9H173 | |
| AKIKEVTERAEDEEE | 921 | Q9Y623 | |
| LEAKIKEVTERAEDE | 916 | P11055 | |
| SEIDRKIAEKDEEIE | 1571 | P11055 | |
| VTEDEVGDEEEVSKK | 566 | Q6NSI8 | |
| EDEDREEAVDTTKKE | 986 | O15047 | |
| EEEDKASEVAIEEEK | 506 | Q5QJE6 | |
| RKEEEEEEEAATVIK | 246 | O00294 | |
| AEEIKKIEEAEREAE | 66 | Q9NZ09 | |
| EKEEDIAVLAEEKIE | 626 | Q8TAF3 | |
| SVEELKEIDVEVRKE | 331 | P08559 | |
| KEIDVEVRKEIEDAA | 336 | P08559 | |
| TAAASEIKREEKEDE | 491 | P15923 | |
| EIKREEKEDEENTSA | 496 | P15923 | |
| EEEEELEETAQEKKL | 66 | O43818 | |
| TQVEEEEEEEDFRKK | 826 | O75717 | |
| EEGKEERTEKEEVGE | 681 | Q9P2H5 | |
| AKVKELTERLEEEEE | 921 | Q9UKX3 | |
| DEEAIKEITEKTRVA | 136 | Q13573 | |
| SEEVREEIAVALKKD | 96 | Q8N567 | |
| EERIHEEFKRKEEEE | 156 | Q5SQS7 | |
| RKITLEVVEEEKVED | 666 | O15041 | |
| ETEIEGQKKVEESRE | 21 | P0C1S8 | |
| KETKEEEEAERSERN | 936 | O95071 | |
| ETERGEVEEDKENKE | 1031 | Q14789 | |
| EEKAEEERKAAEERL | 616 | Q96M32 | |
| KFVEEIIEETKVEDE | 451 | P07197 |